Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Spironolactone most effective for hirsutism, but has side effects.

Minoxidil and finasteride effectively treat hair loss.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Diane 35 plus finasteride is more effective for treating hirsutism.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

SHBG may be a useful early indicator and treatment target for PCOS.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.